Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement

(2017) Julia Seeger et al.   JACC-Cardiovascular Interventions

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease

(2017) Giulia Renda et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial

(2017) Raffaele De Caterina et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Current status of transcatheter mitral valve therapy in Europe: results from an EAPCI survey (Part II)

(2017) Anna Sonia Petronio et al.   EuroIntervention

Anticoagulation Regimens During Pregnancy in Patients With Mechanical Heart Valves: A Systematic Review and Meta-analysis

(2016) Zhe Xu et al.   CANADIAN JOURNAL OF CARDIOLOGY

Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseClinical Perspective

(2016) Michael D. Ezekowitz et al.   CIRCULATION

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation

(2016) Jan Beyer-Westendorf et al.   EUROPACE

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication

(2016) Andreas Goette et al.   EUROPACE

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPACE

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

(2016) Günter Breithardt et al.   HEART

Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

(2016) Omar Abdul-Jawad Altisent et al.   JACC-Cardiovascular Interventions

OUTCOMES IN 2824 PATIENTS WITH VALVULAR HEART DISEASE TREATED WITH EDOXABAN OR WARFARIN IN THE ENGAGE AF-TIMI 48 TRIAL

(2016) Giulia Renda et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Economic evaluation of the new oral anticoagulants for the prevention of thromboembolic events: a cost-minimization analysis

(2016) Milena Soriano Marcolino et al.   Sao Paulo Medical Journal

Spotlight on unmet needs in stroke prevention: The PIONEER AF-PCI, NAVIGATE ESUS and GALILEO trials

(2016) Melanie Hemmrich et al.   THROMBOSIS AND HAEMOSTASIS

Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis

(2016) R. Philippart et al.   THROMBOSIS AND HAEMOSTASIS

Increased bleeding risk in patients with aortic valvular stenosis: From new mechanisms to new therapies

(2016) Joanna Natorska et al.   THROMBOSIS RESEARCH

Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study

(2016) André Rodrigues Durães et al.   Drugs in research & development

Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision‐Making of Aortic Valve Replacement

(2016) Amjad I. Hussain et al.   Journal of the American Heart Association

The Costs of Warfarin Underuse and Nonadherence in Patients with Atrial Fibrillation: A Commercial Insurer Perspective

(2016) Julian P. Casciano et al.   JOURNAL OF MANAGED CARE PHARMACY

Improving Clinical Practice Guidelines for Practicing Cardiologists

(2015) Jesaia Benhorin et al.   AMERICAN JOURNAL OF CARDIOLOGY

How to define valvular atrial fibrillation?

(2015) Laurent Fauchier et al.   Archives of Cardiovascular Diseases

Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseCLINICAL PERSPECTIVE

(2015) Alvaro Avezum et al.   CIRCULATION

Pregnancy in Women With a Mechanical Heart ValveCLINICAL PERSPECTIVE

(2015) Iris M. van Hagen et al.   CIRCULATION

Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device

(2015) Leif I. Bösche et al.   CLINICAL CARDIOLOGY

Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves

(2015) Ajay Yadlapati et al.   Clinical Research in Cardiology

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial

(2015) Raffaele De Caterina et al.   EUROPACE

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference

(2015) Paulus Kirchhof et al.   EUROPACE

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

(2015) Hein Heidbuchel et al.   EUROPACE

Management of valvular disease in pregnancy: a global perspective

(2015) K. Sliwa et al.   EUROPEAN HEART JOURNAL

Prognostic value of CHA2DS2-VASc score in patients with ‘non-valvular atrial fibrillation’ and valvular heart disease: the Loire Valley Atrial Fibrillation Project

(2015) Raphael Philippart et al.   EUROPEAN HEART JOURNAL

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

(2015) S. Schulz-Schupke et al.   EUROPEAN HEART JOURNAL

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin

(2015) Matthew J. Price et al.   JACC-Cardiovascular Interventions

Non-valvular atrial fibrillation

(2015) Giuseppe Boriani et al.   Journal of Cardiovascular Medicine

Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves

(2015) Raj R. Makkar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

(2015) Philip Urban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Empirical relationships between health literacy and treatment decision making: A scoping review of the literature

(2015) Leslie J. Malloy-Weir et al.   PATIENT EDUCATION AND COUNSELING

Antithrombotic therapy in TAVI patients: changing concepts

(2015) Giuseppe Gargiulo et al.   EuroIntervention

Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation

(2015) Iqbal H. Jaffer et al.   Journal of the American Heart Association

Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries

(2014) Jonas Oldgren et al.   CIRCULATION

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

(2014) Rick A. Nishimura et al.   CIRCULATION

The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey

(2014) M. Molteni et al.   EUROPACE

Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)

(2014) Liesl Zühlke et al.   EUROPEAN HEART JOURNAL

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

(2014)   EUROPEAN HEART JOURNAL

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

(2014) Günter Breithardt et al.   EUROPEAN HEART JOURNAL

Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation

(2014) Jeroen J. Bax et al.   EUROPEAN HEART JOURNAL

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

(2014) et al.   EUROPEAN HEART JOURNAL

What is ‘valvular’ atrial fibrillation? A reappraisal

(2014) Raffaele De Caterina et al.   EUROPEAN HEART JOURNAL

Futility, Benefit, and Transcatheter Aortic Valve Replacement

(2014) Brian R. Lindman et al.   JACC-Cardiovascular Interventions

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy

(2014) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Global epidemiology of atrial fibrillation

(2014) Faisal Rahman et al.   Nature Reviews Cardiology

Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control

(2014) Andrej Janzic et al.   PHARMACOECONOMICS

Guidelines for the Primary Prevention of Stroke

(2014) James F. Meschia et al.   STROKE

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Atrial Fibrillation and Aortic Stenosis

(2013) Stefan Stortecky et al.   Circulation-Cardiovascular Interventions

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

(2013) Gregory Y.H. Lip et al.   EUROPACE

Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association

(2013) G. Boriani et al.   EUROPEAN HEART JOURNAL

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

(2013) B. P. Krijthe et al.   EUROPEAN HEART JOURNAL

Atrial fibrillation prevalence revisited

(2013) L. Friberg et al.   JOURNAL OF INTERNAL MEDICINE

Incidence and Cost of Stroke and Hemorrhage in Patients Diagnosed with Atrial Fibrillation in France

(2013) François-Emery Cotté et al.   Journal of Stroke & Cerebrovascular Diseases

Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation

(2013) Vivek Y. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

(2013) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

(2013) Charalampos Kasmeridis et al.   PHARMACOECONOMICS

Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement

(2012) John Webb et al.   CANADIAN JOURNAL OF CARDIOLOGY

The Global Burden of Atrial Fibrillation and Stroke

(2012) Gregory Y.H. Lip et al.   CHEST

Antithrombotic and Thrombolytic Therapy for Valvular Disease

(2012) Richard P. Whitlock et al.   CHEST

Timing, Predictive Factors, and Prognostic Value of Cerebrovascular Events in a Large Cohort of Patients Undergoing Transcatheter Aortic Valve Implantation

(2012) Luis Nombela-Franco et al.   CIRCULATION

Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007

(2012) Jonathan P. Piccini et al.  

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Guidelines on the management of valvular heart disease (version 2012)

(2012) et al.   EUROPEAN HEART JOURNAL

Guidelines on the management of valvular heart disease (version 2012)

(2012) et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding

(2012) Charlotte Mérie et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Transcatheter Valve Replacement for Aortic Stenosis

(2012) Chintan S. Desai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dabigatran versus Warfarin after Mechanical Mitral Valve Replacement in the Swine Model

(2012) John L. Schomburg et al.   JOURNAL OF INVESTIGATIVE SURGERY

New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes

(2012) Raffaele De Caterina et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement

(2012) David R. Holmes et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Long-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial Fibrillation

(2012) Catherine J. Mercaldi et al.   Cardiology Research and Practice

The cost of illness of atrial fibrillation: a systematic review of the recent literature

(2011) S. E. Wolowacz et al.   EUROPACE

Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis

(2011) Guillaume Cayla et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves

(2011) Stephen H. McKellar et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anticoagulation therapy with combined low dose aspirin and warfarin following mechanical heart valve replacement

(2011) Ming-Feng Dong et al.   THROMBOSIS RESEARCH

Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement

(2011) Tillquist et al.   Patient Preference and Adherence

LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the “LOWERING-IT” Trial

(2010) Michele Torella et al.   AMERICAN HEART JOURNAL

Balancing the Risk of Hemorrhage vs Thromboembolism in Patients With Atrial Fibrillation

(2010) Giuseppe Boriani et al.   CHEST

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Relation of the severity of mitral regurgitation to thromboembolic risk in patients with atrial fibrillation

(2009) Nobuyuki Fukuda et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice

(2009) Helmut Baumgartner et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

(2009) Timothy Watson et al.   LANCET

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

(2009) David R Holmes et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Valvular and Structural Heart Disease

(2008) Deeb N. Salem et al.   CHEST

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

(2008) Stuart J. Connolly et al.   CIRCULATION